ATRA
Price
$6.17
Change
+$0.33 (+5.65%)
Updated
Apr 17 closing price
Capitalization
36.15M
VNDA
Price
$4.33
Change
-$0.04 (-0.92%)
Updated
Apr 17 closing price
Capitalization
252.51M
11 days until earnings call
Ad is loading...

ATRA vs VNDA

Header iconATRA vs VNDA Comparison
Open Charts ATRA vs VNDABanner chart's image
Atara Biotherapeutics
Price$6.17
Change+$0.33 (+5.65%)
Volume$23.96K
Capitalization36.15M
Vanda Pharmaceuticals
Price$4.33
Change-$0.04 (-0.92%)
Volume$506.63K
Capitalization252.51M
ATRA vs VNDA Comparison Chart
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. VNDA commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and VNDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (ATRA: $6.17 vs. VNDA: $4.33)
Brand notoriety: ATRA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 40% vs. VNDA: 71%
Market capitalization -- ATRA: $36.15M vs. VNDA: $252.51M
ATRA [@Biotechnology] is valued at $36.15M. VNDA’s [@Biotechnology] market capitalization is $252.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATRA and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).

  • ATRA’s TA Score: 5 bullish, 4 bearish.
  • VNDA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than VNDA.

Price Growth

ATRA (@Biotechnology) experienced а +16.42% price change this week, while VNDA (@Biotechnology) price change was +6.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

ATRA is expected to report earnings on Aug 12, 2024.

VNDA is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($253M) has a higher market cap than ATRA($36.1M). VNDA YTD gains are higher at: -9.603 vs. ATRA (-53.644). VNDA has higher annual earnings (EBITDA): -32.53M vs. ATRA (-75.75M). VNDA has more cash in the bank: 375M vs. ATRA (42.5M). VNDA has less debt than ATRA: VNDA (12.4M) vs ATRA (43.8M). VNDA has higher revenues than ATRA: VNDA (199M) vs ATRA (129M).
ATRAVNDAATRA / VNDA
Capitalization36.1M253M14%
EBITDA-75.75M-32.53M233%
Gain YTD-53.644-9.603559%
P/E RatioN/A137.00-
Revenue129M199M65%
Total Cash42.5M375M11%
Total Debt43.8M12.4M353%
FUNDAMENTALS RATINGS
ATRA vs VNDA: Fundamental Ratings
ATRA
VNDA
OUTLOOK RATING
1..100
1911
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
3574
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRA's Valuation (77) in the Biotechnology industry is in the same range as VNDA (84). This means that ATRA’s stock grew similarly to VNDA’s over the last 12 months.

ATRA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VNDA (100). This means that ATRA’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (91) in the Biotechnology industry is in the same range as ATRA (100). This means that VNDA’s stock grew similarly to ATRA’s over the last 12 months.

ATRA's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for VNDA (74). This means that ATRA’s stock grew somewhat faster than VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ATRA (100). This means that VNDA’s stock grew significantly faster than ATRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRAVNDA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 10 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with AMLX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+5.65%
AMLX - ATRA
65%
Loosely correlated
+4.19%
GRI - ATRA
40%
Loosely correlated
-1.31%
SLRX - ATRA
39%
Loosely correlated
+0.79%
NTLA - ATRA
36%
Loosely correlated
+5.39%
FULC - ATRA
35%
Loosely correlated
+7.52%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IKNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-0.92%
IKNA - VNDA
37%
Loosely correlated
N/A
CLDX - VNDA
36%
Loosely correlated
+2.81%
SNGX - VNDA
32%
Poorly correlated
+1.94%
REPL - VNDA
30%
Poorly correlated
+4.78%
ATRA - VNDA
30%
Poorly correlated
+5.65%
More